NICE and NHS England publish more Spinraza Q&As

Published Date
09/06/2020
Author
Laura Burge
Category
Care & Support
Spinraza SMA treatment

NICE, NHS England and NHS Improvement have taken advice from clinical experts and consulted with patient advisory groups Muscular Dystrophy UK, Treat SMA, and SMA UK to produce three more question-and-answer documents relating to the SMA treatment Spinraza.

The first document, which answers questions about Spinraza and how it works, can be found here.

The second document answers questions about the treatment process, and you can read it here.

The final document answers questions about the collection of data relating to the treatment. You can find this information here. 

There are also two documents published last month about access to the treatment for children and the Managed Access Agreement (MAA).

You can find out more about Spinraza here. If you have any questions about access to the treatment, speak to your clinician.

Keep in touch